Summit Session Title:

"Innovative Nanomaterials Redefine "High-Performance" Semiconductors"

Topic Summary:

Defining "high-performance" today requires consideration of a longer list of variables than ever before. It is no longer sufficient for semiconductor manufacturers to deliver products with the right mix of processing performance and power. They must also deliver these products at the right time and at the right price. Meeting consumer demand for increasingly advanced applications while balancing these complex variables will require innovative materials. Join Dr. Douglas Grose, senior vice president of technology development, manufacturing and supply chain for AMD, and some of the nanotechnology industry’s most compelling thought leaders as they discuss advances in nanomaterials. Panelists will discuss how the IC industry is integrating these new and multi-functional materials into silicon technology to enable new applications, the improvements in performance and power capability these materials provide, and the challenges and solutions for bringing these products to market.


Summit Panelists include:
Dr. Douglas Grose - Chair - AMD Sr. VP - Technology Manufacturing and Supply Chain

Dr. Sanjay Banerjee, University of Texas at Austin, Cockrell Family Regents Chair in Electrical & Computer Eng. and Director, Microelectronics Research Center

David Moxam, CEO Authentix

Dr. Ed Schlesinger, Carnegie Mellon University Professor & Head Electrical and Computer Engineering

Dr. Horst Adams, ALCAN Technology & Management LTD. Manager Technology Services

Dr. Mark Melliar-Smith, CEO & President, Molecular Imprints, Inc.

David Lazovsky, President & CEO, Intermolecular, Inc.

Dr. Shawn Searles, AMD

The Advanced Materials Summit will take place at the nanoTX’07 Conference and Trade Expo, Wednesday, October 3, at 3:30 pm in the Business Hall A, Stage 2. All expo attendees are welcome.

Summit Session Title:

"Beyond CMOS"

Topic Summary:

The "Beyond CMOS" Summit will explore challenges and potential solutions for logic and memory devices that could continue the historical improvement trends of integrated circuits beyond the projected limits of CMOS (Complementary-Metal-Oxide-Semiconductor) technology. For over forty years, the electronics industry has enjoyed rapid advances in the speed, power consumption, and cost per function of integrated circuits. This has resulted mainly from the ability to further miniaturize ("scale") bipolar and, subsequently, MOS transistors and their interconnections. It is generally conceded that CMOS technology is rapidly approaching its practical limits of scaling. Can we invent anything to supersede it?

Summit Panelists include:
Dr. Robert R. Doering - Chair - Texas Instruments, Senior Fellow & Tech. Strategy Manager, Office of the CTO

Dr. Sanjay Banerjee, University of Texas at Austin, Cockrell Family Regents Chair in Electrical & Computer Eng. and Director, Microelectronics Research Center

Dr. Yehia Massoud, Rice University, Associate Professor, Depts. of Electrical & CE & CS

Dr. Bruce Gnade, University of Texas at Dallas, VP for Research

Dr. Allan MacDonald, University of Texas at Austin, Professor

Dr. Sean C. O'Brien, Texas Instruments, Senior Member Technical Staff

Dr. Jairo Sinova, Texas A&M University, Department of Physics

Dr. John Shumway, Arizona State University, Associate Professor, Department of Physics

The Beyond CMOS Summit will take place at the nanoTX’07 Conference and Trade Expo, Thursday, October 4, at 10:30 am in the Business Hall A, Stage 2. All expo attendees are welcome.

Summit Session Title:

"Scaling CMOS to its Ultimate Limits"

Topic Summary:



Summit Panelists include:
Dr. Walt Trybula - Chair - Texas State University, Director Nanomaterials Application Center

Mark Hakey, IBM Corporation, Distinguished Engineer/Manager of Advanced Process Technology

Dr. Sean C. O'Brien, Texas Instruments, Senior Member Technical Staff

Dr. Eric M. Vogel, University of Texas at Dallas, Associate Professor

Dr. Kang L Wang, UCLA, Raytheon Chair Professor of Physical Sciences

The Scaling CMOS Summit will take place at the nanoTX’07 Conference and Trade Expo, Wednesday, October 3, at 10:30 am in the Business Hall A, Stage 2. All expo attendees are welcome.

Summit Session 1 Title:

"Nanotechnology for Medical Diagnostics"

Topic Summary:

The early detection of cancer, heart disease and other medical conditions greatly improves the likelihood of complete cure. Nanotechnology offers unprecedented opportunities in diagnostic laboratory tests on blood and other biological fluids, which have the potential to bring about early and affordable mass screenings for the major diseases. Nanotechnology-based contrast agents for radiological imaging are emerging, which couple the promise of improved determination of the size, shape and location of pathological condition with the simultaneous identification of cell- and molecule-level abnormalities. These changes will enable doctors to choose the most appropriate therapeutic regimens for individual patients, and to monitor their efficacy in real time.

Summit Panelists include:
Dr. Russell M. Lebovitz - Chair - Suma Partners, L.P, Partner

Dr. Jodie Conyers, UT Health Science Center, Director - Office of Biotech

Dr. Vittorio Cristini, UT Health Science Center, Assistant Professor - HIS

Dr. Chun Li, MD Anderson Cancer Center, Professor

The Alliance for NanoHealth Summit will take place at the nanoTX’07 Conference and Trade Expo, Wednesday, October 3, at 1:30 pm in the Business Hall A, Stage 1.


Summit Session 2 Title:

"Nanotechnology-Based Medical Therapeutics"

Topic Summary:

Nanotechnology will contribute greatly to the solution of two fundamental problems in medicine: Delivering therapy at the right place and at the right time. Our current inability to attain these goals has dramatically impaired progress towards the eradication of cancer, heart disease, and other medical conditions. Nanomedicine’s contributions to the localization of therapy on target sites features the combination of biological target recognition, and the ability to avoid the many, daunting biological barriers that the body employs against foreign substances - medical drugs included. The ability to deliver therapy in a spatially and temporally selective manner will increase therapeutic efficacy, reduce side effects, and afford the personalization of treatment.

Summit Panelists include:
Dr. Russell M. Lebovitz - Chair - Suma Partners, L.P, Partner

Dr. Peter Gascoyne, MD Anderson Cancer Center, Professor, Molecular Pathology

The Alliance for NanoHealth Summit 2 will take place at the nanoTX’07 Conference and Trade Expo, Thursday, October 4, at 12:30 pm in the Business Hall A, Stage 1. All expo attendees are welcome.

Summit Session 1 Title:

"Energy Harvesting, Conversion & Storage I"

Topic Summary:



Summit Session 2 Title:

"Energy Harvesting, Conversion & Storage II"

Topic Summary:

Summit Session 1 Title:

"Nanoparticles- Do protective measures really protect workers?"

Topic Summary:

The small size of nanoparticles raises a number of questions regarding workplace protections, including: how accurately can we detect and monitor engineered nanoparticles in ambient air? on surfaces? Do HEPA filters have any gaps in terms of particle size? How well do standard gloves and other protective clothing block out nanoparticles? This session will assemble experts in workplace protection and nanoparticle monitoring from around the country to present the latest science and best practices in workplace protection for the nanotechnology industries.

Summit Panelists include:
Dr. John M. Balbus - Co-Chair - Environmental Defense, Director, Health Program

Dr. Kristen Kulinowski - Co-Chair - Rice University, Executive Director - CBEN

Dr. Andrew D. Maynard - Co-Chair - Woodrow Wilson Int'l. Center, Chief Science Advisor

Dr. Charles L. Geraci, NIOSH, Chief, Document Development Branch

Dr. Douglas B. Trout, NIOSH, Associate Director for Science

Gregory M. Olson, Jr., TSI, Sr. Industrial Hygienist

David Pui, University of Minnesota

The EH&S Summit will take place at the nanoTX’07 Conference and Trade Expo, Wednesday, October 3, at 1:30 pm in the Business Hall A, Stage 1. All expo attendees are welcome.


Summit Session 2 Title:

"Containing the unknown: Risk management frameworks for nanotechnology product development"

Topic Summary:

In the past year, a number of different guidance documents for assessing and managing potential environmental and health risks from nanotechnology products have been developed and published. In addition, several consulting firms have developed their own approaches for assisting companies with risk management. In the absence of specific regulations, these documents and consultants provide companies with critical environmental health and safety information but also with different approaches to assessing potential toxicity of nanotechnology products. This session will introduce the audience to the different risk management approaches and showcase their commonalities and differences.

Summit Panelists include:
Dr. John M. Balbus - Co-Chair - Environmental Defense, Director, Health Program

Dr. Kristen Kulinowski - Co-Chair - Rice University, Executive Director - CBEN

Dr. Andrew D. Maynard - Co-Chair - Woodrow Wilson Int'l. Center, Chief Science Advisor

Matthew S. Hull, Luna Innovations Incorporated, Principal Investigator

Dr. Christopher M. Long, Gradient Corporation, Principal Scientist

Dr. Jo Anne Shatkin, CLF Ventures, Managing Director

The EH&S Summit 2 will take place at the nanoTX’07 Conference and Trade Expo, Thursday, October 4, at 10:30 am in the Business Hall A, Stage 1. All expo attendees are welcome.